[go: up one dir, main page]

BR9509671C1 - Derivados de dibenzimidazol - Google Patents

Derivados de dibenzimidazol

Info

Publication number
BR9509671C1
BR9509671C1 BR9509671-0A BR9509671A BR9509671C1 BR 9509671 C1 BR9509671 C1 BR 9509671C1 BR 9509671 A BR9509671 A BR 9509671A BR 9509671 C1 BR9509671 C1 BR 9509671C1
Authority
BR
Brazil
Prior art keywords
derivatives
alkoxy
formula
dibenzimidazole derivatives
dibenzimidazoles
Prior art date
Application number
BR9509671-0A
Other languages
English (en)
Other versions
BR9509671A (pt
Inventor
Walter Haesler
Yu-Hua Ji
Werner Leupin
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of BR9509671A publication Critical patent/BR9509671A/pt
Publication of BR9509671C1 publication Critical patent/BR9509671C1/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/20—Two benzimidazolyl-2 radicals linked together directly or via a hydrocarbon or substituted hydrocarbon radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Patente de Invenção: "DERIVADOS DE DIBENZIMIDAZOL". Dibenzimidazóis novos e conhecidos da fórmula: onde: R^ 1^ e R^ 2^ podem ser os mesmos ou diferentes e significam C~ 6~H~ 4~ R^ 3^-, C~ 6~H~ 3~(OH)R^ 4^ - ou heterociclila, R^ 3^ significa hidróxi, amino, alcóxi inferior ou ciano e R^ 4^ significa halogênio, alquila inferior ou alcóxi inferior, bem como sais farmaceuticamente utilizáveis dos compostos da fórmula geral I são antibacterianos, especialmente contra Staphylococcus, Enterococcus e Heliobacter pylori.
BR9509671-0A 1994-11-17 1995-11-02 Derivados de dibenzimidazol BR9509671C1 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH345994 1994-11-17
PCT/CH1995/000255 WO1996016042A1 (de) 1994-11-17 1995-11-02 Antibakterielle dibenzimidazol-derivate

Publications (2)

Publication Number Publication Date
BR9509671A BR9509671A (pt) 1997-10-28
BR9509671C1 true BR9509671C1 (pt) 2000-04-18

Family

ID=4256402

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9509671-0A BR9509671C1 (pt) 1994-11-17 1995-11-02 Derivados de dibenzimidazol

Country Status (9)

Country Link
US (1) US5824698A (pt)
EP (1) EP0793654A1 (pt)
JP (1) JPH09512831A (pt)
AU (1) AU3696495A (pt)
BR (1) BR9509671C1 (pt)
CA (1) CA2204639A1 (pt)
FI (1) FI972090A7 (pt)
MX (1) MX9703634A (pt)
WO (1) WO1996016042A1 (pt)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2150274C1 (ru) * 1996-12-26 2000-06-10 Бачин Игорь Валентинович Стабилизированная водорастворимая композиция трийодида 1,2,3-триалкилбензимидазолия
RU2135476C1 (ru) * 1998-12-07 1999-08-27 Ливицкий Василий Иванович Дийодбромиды 1,2,3-замещенных бензимидазолия и их водорастворимая композиция
GB9908828D0 (en) * 1999-04-16 1999-06-16 Univ Reading The Compounds
JP2003501488A (ja) * 1999-06-11 2003-01-14 ネオルックス コーポレイション 骨髄抑制のための高投与量放射性核種錯体
US7094885B2 (en) * 1999-07-11 2006-08-22 Neorx Corporation Skeletal-targeted radiation to treat bone-associated pathologies
US6403652B1 (en) 2000-06-30 2002-06-11 Colgate-Palmolive Company Method and composition
AU2002249935A1 (en) 2001-01-08 2002-08-19 Neorx Corporation Radioactively labelled conjugates of phosphonates
US7701130B2 (en) 2001-08-24 2010-04-20 Semiconductor Energy Laboratory Co., Ltd. Luminous device with conductive film
WO2003051403A1 (en) 2001-12-13 2003-06-26 Dow Global Technologies Inc. Treatment of osteomyelitis with radiopharmaceuticals
KR100629060B1 (ko) * 2004-08-11 2006-09-26 주식회사 엘지화학 새로운 벤즈이미다졸계 화합물
DE102005017508A1 (de) * 2005-04-15 2006-10-19 Basf Ag Verfahren zur Gewinnung einer basischen Aminosäure aus einer Fermentationsbrühe II
GB0821913D0 (en) 2008-12-02 2009-01-07 Price & Co Antibacterial compounds
WO2011151617A1 (en) 2010-06-01 2011-12-08 Summit Corporation Plc Compounds for the treatment of clostridium difficile associated disease
WO2011151619A1 (en) 2010-06-01 2011-12-08 Summit Corporation Plc Compounds for the treatment of clostridium difficile associated disease
GB2480813A (en) * 2010-06-01 2011-12-07 Summit Corp Plc Compounds for the treatment of clostridium difficile-associated disease
GB2480814A (en) * 2010-06-01 2011-12-07 Summit Corp Plc Compounds for the treatment of clostridium difficile-associated disease
WO2011151620A1 (en) 2010-06-01 2011-12-08 Summit Corporation Plc Compounds for the treatment of clostridium difficile associated disease
BR112012030621B1 (pt) 2010-06-01 2020-10-27 Summit (Oxford) Limited compostos para o tratamento de doença associada a clostridium difficile
WO2011151618A2 (en) 2010-06-01 2011-12-08 Summit Corporation Plc Compounds for the treatment of clostridium difficile-associated disease
US9079935B2 (en) 2012-08-13 2015-07-14 The Board Of Regents Of The Nevada System Of Higher Education On Behalf Of The University Of Nevada, Las Vegas Reducing risk of contracting Clostridium-difficile associated disease
US20180000793A1 (en) 2015-02-06 2018-01-04 Ernesto Abel-Santos Inhibiting Germination of Clostridium Perfringens Spores to Reduce Necrotic Enteritis
JP7730803B2 (ja) 2019-07-17 2025-08-28 サミット （オックスフォード） リミティド リジニラゾールの調製方法およびその結晶形態
GB202100470D0 (en) 2021-01-14 2021-03-03 Summit Oxford Ltd Solid tablet dosage for of ridinilazole
GB202100471D0 (en) 2021-01-14 2021-03-03 Summit Oxford Ltd Preparation of antibacterial compounds
WO2023039159A2 (en) 2021-09-09 2023-03-16 Abel Santos Ernesto Inhibitors of c. difficile spore germination

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4087409A (en) * 1966-11-07 1978-05-02 Monsanto Company Ordered heterocyclic copolymers
US3484407A (en) * 1967-01-13 1969-12-16 Monsanto Co Linear condensation polymers containing carbonamide and heterocyclic linkages
US3592821A (en) * 1968-05-21 1971-07-13 Ciba Ltd 2-(2'-hydroxy-3',5'-dichlorophenyl)-5-chloro- or 5-methylbenzimidazoles
US4665066A (en) * 1984-12-24 1987-05-12 Eli Lilly And Company 3-thiazolomethyl cephalosporins as antibiotics
US4960790A (en) * 1989-03-09 1990-10-02 University Of Kansas Derivatives of taxol, pharmaceutical compositions thereof and methods for the preparation thereof
US5412059A (en) * 1993-04-05 1995-05-02 The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration Polybenzimidazoles via aromatic nucleophilic displacement

Also Published As

Publication number Publication date
MX9703634A (es) 1997-08-30
AU3696495A (en) 1996-06-17
FI972090A0 (fi) 1997-05-15
EP0793654A1 (de) 1997-09-10
FI972090L (fi) 1997-05-15
WO1996016042A1 (de) 1996-05-30
BR9509671A (pt) 1997-10-28
US5824698A (en) 1998-10-20
CA2204639A1 (en) 1996-05-30
FI972090A7 (fi) 1997-05-15
JPH09512831A (ja) 1997-12-22

Similar Documents

Publication Publication Date Title
BR9509671C1 (pt) Derivados de dibenzimidazol
BR0109703A (pt) Derivados de piperazina
BR0015254A (pt) Derivados de carbamoiloxialquil-azólio substituìdos em n
NO991974L (no) 5-HT1F agonister
TR200200579T2 (tr) Amino-tirazolpiridin türevleri.
WO2003080582A3 (de) Fredericamycin-derivate
PT1347971E (pt) Inibidores tiazolilicos de tirosina-cinases da familia tec
BR0215240A (pt) Derivados de calcona e seu uso no tratamento de doenças
BR0212042A (pt) Composto, composição farmacêutica, método de tratamento ou prevenção de doenças, e, uso de um composto
DE50310516D1 (de) Fredericamycin-derivate
DK0889876T3 (da) Meta-substituerede phenylensulfonamidderivater
ATE375990T1 (de) Piperidin-indol derivate mit 5-ht6 affinität
PT1017675E (pt) Derivados da camtotecina altamente lipofilos
ATE222115T1 (de) Verbesserung der antibakteriellen wirkung von oxazolidinon durch arginin derivate
BRPI0418255A (pt) derivados de piperazina e piperidina n-substituìdos
BR0315662A (pt) Derivados de 1-(4-benzil-piperazin-1-il)-3-fenil-propenona
BR0014990A (pt) Derivados de tetrahidrotiopirano ranftalazinona como inibidores de pde4
BR9812922A (pt) Isoquinolinas como inibidores de uroquinase
DE69937301D1 (de) Aminosterolderivate und ihre verwendungen
BR0114697A (pt) Derivados em ponte de piperazina
BR0213037A (pt) Derivados de pirimidina
BR0308071A (pt) Inibidores da protéina farnesil transferase como agentes antitumores
BR0001201A (pt) Composto ( poli ) tia-alcinóicos, composição cosmética, utilização de uma composição cosmética, utilização de um composto e composição farmacêutica
BR0012184A (pt) Derivados de indol
BR9814188A (pt) "agonistas de 5-ht1f"

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]